Ameritas Investment Partners’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7,887
| Closed | -$16K | – | 3341 |
|
|
2022
Q1 | $16K | Hold |
7,887
| – | – | ﹤0.01% | 2658 |
|
|
2021
Q4 | $21K | Hold |
7,887
| – | – | ﹤0.01% | 2635 |
|
|
2021
Q3 | $35K | Hold |
7,887
| – | – | ﹤0.01% | 2386 |
|
|
2021
Q2 | $46K | Buy |
7,887
+1,500
| +23% | +$8.75K | ﹤0.01% | 2253 |
|
|
2021
Q1 | $45K | Hold |
6,387
| – | – | ﹤0.01% | 2150 |
|
|
2020
Q4 | $31K | Hold |
6,387
| – | – | ﹤0.01% | 2267 |
|
|
2020
Q3 | $37K | Hold |
6,387
| – | – | ﹤0.01% | 2032 |
|
|
2020
Q2 | $43K | Buy |
6,387
+2,420
| +61% | +$16.3K | ﹤0.01% | 1930 |
|
|
2020
Q1 | $25K | Hold |
3,967
| – | – | ﹤0.01% | 2063 |
|
|
2019
Q4 | $41K | Hold |
3,967
| – | – | ﹤0.01% | 2035 |
|
|
2019
Q3 | $16K | Hold |
3,967
| – | – | ﹤0.01% | 2524 |
|
|
2019
Q2 | $59K | Hold |
3,967
| – | – | ﹤0.01% | 1834 |
|
|
2019
Q1 | $98K | Hold |
3,967
| – | – | ﹤0.01% | 1487 |
|
|
2018
Q4 | $71K | Hold |
3,967
| – | – | ﹤0.01% | 1607 |
|
|
2018
Q3 | $117K | Hold |
3,967
| – | – | 0.01% | 1452 |
|
|
2018
Q2 | $180K | Buy |
3,967
+242
| +6% | +$11K | 0.01% | 1126 |
|
|
2018
Q1 | $197K | Hold |
3,725
| – | – | 0.01% | 1080 |
|
|
2017
Q4 | $253K | Hold |
3,725
| – | – | 0.01% | 976 |
|
|
2017
Q3 | $283K | Hold |
3,725
| – | – | 0.01% | 901 |
|
|
2017
Q2 | $349K | Buy |
3,725
+655
| +21% | +$61.4K | 0.02% | 837 |
|
|
2017
Q1 | $195K | Buy |
+3,070
| New | +$195K | 0.01% | 1077 |
|